Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.
about
Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Immune response and survival o ...... gous tumor cell (TAG) vaccine.
@en
Immune response and survival o ...... modified autologous tumor cell
@nl
type
label
Immune response and survival o ...... gous tumor cell (TAG) vaccine.
@en
Immune response and survival o ...... modified autologous tumor cell
@nl
prefLabel
Immune response and survival o ...... gous tumor cell (TAG) vaccine.
@en
Immune response and survival o ...... modified autologous tumor cell
@nl
P2093
P2860
P356
P1433
P1476
Immune response and survival o ...... gous tumor cell (TAG) vaccine.
@en
P2093
B O Pappen
G Wallraven
J Nemunaitis
J Olivares
P B Maples
P2860
P2888
P304
P356
10.1038/GT.2013.9
P577
2013-03-07T00:00:00Z